国际眼科杂志Issue(2)：263-265,3.DOI:10.3980/j.issn.1672-5123.2014.02.17
增生性玻璃体视网膜病变的治疗进展
Treatment progress on proliferative vitreoretinopathy
王建伟 1林铁柱 1李世洋1
作者信息
- 1. 471031 中国河南省洛阳市，解放军第150中心医院眼科
- 折叠
摘要
Abstract
Proliferative vitreoretinopathy ( PVR ) is a disease process that follows the proliferation of ectopic cell sheets in the vitreous and/or periretinal area, causing periretinal membrane formation, shrink and traction, in patients with rhegmatogenous retinal detachments. Pars plana vitrectomy is the standard treatment currently.There are many new drug therapies according to the functions of cytokines and growth factors in PVR, including anti -inflammatories, antineoplastic agents, antigrowth factors, and so on.关键词
增生性玻璃体视网膜病变/视网膜脱离/生长因子Key words
proliferative vitreoretinopathy/retinal detachment/growth factor引用本文复制引用
王建伟,林铁柱,李世洋..增生性玻璃体视网膜病变的治疗进展[J].国际眼科杂志,2014,(2):263-265,3.
